Fish Oil Supplements

Medical Letter on Drugs and Therapeutics

Volumn 54, Issue 1401, 2012, Pages 83-84

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; FISH OIL; GEMFIBROZIL; GLUCOSE; ICOSAPENTAENOIC ACID ETHYL ESTER; NICOTINIC ACID; OLIVE OIL; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

BLEEDING; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE SEVERITY; DYSPEPSIA; ERUCTATION; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HIGH RISK POPULATION; HUMAN; HYPERTRIGLYCERIDEMIA; LETTER; MORTALITY; PRIMARY PREVENTION; RECURRENT DISEASE; RHABDOMYOLYSIS; SECONDARY PREVENTION; SIDE EFFECT; TASTE DISORDER; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

DIETARY SUPPLEMENTS; DRUG APPROVAL; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84870608358     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. G Einvik et al. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010; 17:558.
2. B Rauch et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010; 122:2152.
3. P Galan et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010; 341:c6273.
4. PR Kowey et al. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 2010; 304:2363.
5. SM Kwak et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012; 172:686.
6. EC Rizos et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012; 308:1024.
7. ORIGIN Trial Investigators. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012; 367: 309.
8. Drugs for lipids. Treat Guidel Med Lett 2011; 53:13.